Pfizer CEO Rethinks Germany Investments Amid Reform Concerns | Pharma and Biotech Daily
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. The pharmaceutical and biotech industries are undergoing significant transformations, driven by scientific advancements, regulatory changes, and strategic investments. These developments are shaping the landscape of drug development and patient care in profound ways. In recent news, Pfizer's CEO, Albert Bourla, is reconsidering investments in Germany due to pro...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Pharma and BioTech Daily
Novartis' $23M RNA Breakthrough & Tavneos FDA Battle | Pharma and Biotech Daily
Takeda's Zasocitinib Beats Sotyktu in Phase 3 Trial | Pharma and Biotech Daily
Merck & Gilead's HIV Pill Breakthrough: Phase 3 Success! | Pharma and Biotech Daily
Eli Lilly's Retatrutide Breakthrough: 30.3% Weight Loss Success | Pharma and Biotech Daily
Get summaries like this every morning.
Free AI-powered recaps of Pharma and BioTech Daily and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.